IAG Wealth Partners’s Thermo Fisher Scientific TMO Stock Holding History

IAG Wealth Partners’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$64.7K	Sell	129 -24	-16%	-$11.5K	0.01%	197
2026 Q1	$75.2K	Buy	153 +24	+19%	+$13K	0.01%	182
2025 Q4	$74.7K	Hold	129	–	–	0.01%	179
2025 Q3	$62.6K	Hold	129	–	–	0.01%	195
2025 Q2	$52.3K	Hold	129	–	–	0.01%	196
2025 Q1	$64.2K	Hold	129	–	–	0.01%	180
2024 Q4	$67.1K	Hold	129	–	–	0.01%	175
2024 Q3	$79.8K	Hold	129	–	–	0.01%	151
2024 Q2	$71.3K	Hold	129	–	–	0.01%	152
2024 Q1	$75K	Hold	129	–	–	0.02%	136
2023 Q4	$68.5K	Hold	129	–	–	0.02%	134
2023 Q3	$65.3K	Hold	129	–	–	0.02%	127
2023 Q2	$67.3K	Hold	129	–	–	0.02%	139
2023 Q1	$74.4K	Hold	129	–	–	0.02%	115
2022 Q4	$71K	Sell	129 -14	-10%	-$7.42K	0.02%	115
2022 Q3	$73K	Buy	143 +6	+4%	+$3.36K	0.02%	100
2022 Q2	$74K	Hold	137	–	–	0.02%	103
2022 Q1	$81K	Buy	137 +8	+6%	+$4.6K	0.03%	103
2021 Q4	$86K	Hold	129	–	–	0.03%	99
2021 Q3	$74K	Hold	129	–	–	0.03%	99
2021 Q2	$66K	Buy	129 +12	+10%	+$5.66K	0.02%	103
2021 Q1	$54K	Hold	117	–	–	0.02%	105
2020 Q4	$55K	Hold	117	–	–	0.02%	105
2020 Q3	$52K	Hold	117	–	–	0.02%	104
2020 Q2	$43K	Buy	+117	New	+$39.2K	0.02%	110

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

IAG Wealth Partners's TMO Position: Q2 2026 in Review

IAG Wealth Partners reduced its Thermo Fisher Scientific (TMO) stake by 16% in Q2 2026, selling an estimated $11.5K and leaving 129 shares worth $64.7K. The position accounts for 0.01% of the portfolio, ranked #197.

IAG Wealth Partners first reported a position in TMO in Q2 2020 and has held it in 25 quarters since. The position peaked at $86K in Q4 2021. 2,624 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

IAG Wealth Partners held 129 shares of Thermo Fisher Scientific worth $64.7K as of Q2 2026.
IAG Wealth Partners sold 24 Thermo Fisher Scientific shares in Q2 2026, an estimated $11.5K.
Thermo Fisher Scientific made up 0.01% of IAG Wealth Partners's portfolio in Q2 2026, its #197 holding.
IAG Wealth Partners first reported a position in Thermo Fisher Scientific in Q2 2020 and has held it in 25 quarters since.
IAG Wealth Partners's Thermo Fisher Scientific position peaked at $86K in Q4 2021.
2,624 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on IAG Wealth Partners's 13F filing for Q2 2026, filed 6 Aug 2026.